Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial

BACKGROUND: Although the loss of bone mineral density (BMD) after total hip arthroplasty (THA) is a known problem, it remains unresolved. This study prospectively examined the effect of zoledronic acid (ZA) on bone turnover and BMD after cementless THA. METHODS: Between January 2010 and August 2011,...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tsan-Wen, Wang, Chao-Jan, Shih, Hsin-Nung, Chang, Yuhan, Huang, Kuo-Chin, Peng, Kuo-Ti, Lee, Mel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441106/
https://www.ncbi.nlm.nih.gov/pubmed/28532408
http://dx.doi.org/10.1186/s12891-017-1577-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441106/
https://www.ncbi.nlm.nih.gov/pubmed/28532408
http://dx.doi.org/10.1186/s12891-017-1577-2

Ejemplares similares